Literature DB >> 3675715

Smooth muscle cell migration and proliferation: atherogenic mechanisms in hypertension.

J Grünwald1, A V Chobanian, C C Haudenschild.   

Abstract

The proliferative and migratory behavior of explanted rat aortic smooth muscle cells (SMC) was investigated in cells obtained from either 24-week-old normotensive Wistar-Kyoto (WKY) or age-matched spontaneously hypertensive (SHR) rats. Time lapse video analysis of primary SMC growth in the presence of 10% serum revealed that interdivision times of cells from SHR were significantly shorter than those from WKY. Differences in the proliferative capacity of these cells were still present after two subcultivations, as analyzed by conventional growth curves. In contrast to the proliferative behavior, no differences in the migratory characteristics of SMC could be detected in a migration assay analyzing the SMC outgrowth of standardized aortic explants under low serum conditions (0.1% fetal bovine serum). It has been shown that another model of hypertension, the 4 week DOC/salt hypertensive rat results in a different reaction of SMC. Therefore, it can be considered that the extent of the potentially atherogenic alterations of SMC function in hypertension is dependent on the type, duration and the rate of increase of hypertension.

Entities:  

Mesh:

Year:  1987        PMID: 3675715     DOI: 10.1016/0021-9150(87)90281-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 2.  Smooth muscle cell phenotypic switching in atherosclerosis.

Authors:  Delphine Gomez; Gary K Owens
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

3.  Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts.

Authors:  M K O'Donohoe; L B Schwartz; Z S Radic; E M Mikat; R L McCann; P O Hagen
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.